CS230614B1 - Analogues of realising factor for luteining and folliculstimulated hormon - Google Patents

Analogues of realising factor for luteining and folliculstimulated hormon Download PDF

Info

Publication number: CS230614B1
Authority: CS; Czechoslovakia
Prior art keywords: pro; arg; tle; leu; solution
Prior art date: 1982-08-06

Application number

CS825868A

Other languages

Czech (cs)

English (en)

Inventor

Martin Cs Flegel

Jan Pospisek

Josef Picha

Drahomira Pichova

Milan Krojidlo

Jiri Kolinsky

Original Assignee

Martin Cs Flegel

Jan Pospisek

Josef Picha

Drahomira Pichova

Milan Krojidlo

Jiri Kolinsky

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-08-06

Filing date

1982-08-06

Publication date

1984-08-13

1982-08-06 Application filed by Martin Cs Flegel, Jan Pospisek, Josef Picha, Drahomira Pichova, Milan Krojidlo, Jiri Kolinsky filed Critical Martin Cs Flegel

1982-08-06 Priority to CS825868A priority Critical patent/CS230614B1/cs

1983-07-26 Priority to AT0271583A priority patent/AT387026B/de

1983-07-27 Priority to SE8304158A priority patent/SE456345B/sv

1983-08-02 Priority to FR8312707A priority patent/FR2531952B1/fr

1983-08-02 Priority to IT22397/83A priority patent/IT1165473B/it

1983-08-03 Priority to GB08320922A priority patent/GB2125408B/en

1983-08-03 Priority to BE0/211294A priority patent/BE897455A/fr

1983-08-04 Priority to DE19833328235 priority patent/DE3328235A1/de

1983-08-04 Priority to JP58141977A priority patent/JPS5959654A/ja

1983-08-05 Priority to CA000434011A priority patent/CA1206959A/fr

1983-08-05 Priority to CH4271/83A priority patent/CH658662A5/de

1983-08-05 Priority to HU832783A priority patent/HU192962B/hu

1983-08-05 Priority to YU1633/83A priority patent/YU45144B/xx

1983-08-08 Priority to US06/521,108 priority patent/US4512923A/en

1984-08-13 Publication of CS230614B1 publication Critical patent/CS230614B1/cs

Links

125000006239 protecting group Chemical group 0.000 claims abstract description 5
229940088597 hormone Drugs 0.000 claims abstract description 4
239000005556 hormone Substances 0.000 claims abstract description 4
230000001456 gonadotroph Effects 0.000 claims abstract 2
230000004936 stimulating effect Effects 0.000 claims 1
239000003814 drug Substances 0.000 abstract description 4
102000012673 Follicle Stimulating Hormone Human genes 0.000 abstract description 3
108010079345 Follicle Stimulating Hormone Proteins 0.000 abstract description 3
102000009151 Luteinizing Hormone Human genes 0.000 abstract description 3
108010073521 Luteinizing Hormone Proteins 0.000 abstract description 3
229940028334 follicle stimulating hormone Drugs 0.000 abstract description 3
229940040129 luteinizing hormone Drugs 0.000 abstract description 3
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
239000000243 solution Substances 0.000 description 18
239000000047 product Substances 0.000 description 14
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
239000000203 mixture Substances 0.000 description 12
230000000694 effects Effects 0.000 description 11
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
239000012071 phase Substances 0.000 description 10
239000000126 substance Substances 0.000 description 10
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
150000001413 amino acids Chemical class 0.000 description 9
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
108090000765 processed proteins & peptides Proteins 0.000 description 8
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 7
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 7
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
238000004458 analytical method Methods 0.000 description 7
102000004196 processed proteins & peptides Human genes 0.000 description 7
239000011541 reaction mixture Substances 0.000 description 7
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
238000004811 liquid chromatography Methods 0.000 description 6
230000004071 biological effect Effects 0.000 description 5
239000006260 foam Substances 0.000 description 5
238000000034 method Methods 0.000 description 5
239000002904 solvent Substances 0.000 description 5
238000006467 substitution reaction Methods 0.000 description 5
XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 4
230000005526 G1 to G0 transition Effects 0.000 description 4
HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 4
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
150000001875 compounds Chemical class 0.000 description 4
238000001514 detection method Methods 0.000 description 4
238000001704 evaporation Methods 0.000 description 4
230000008020 evaporation Effects 0.000 description 4
239000000741 silica gel Substances 0.000 description 4
229910002027 silica gel Inorganic materials 0.000 description 4
JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
238000009833 condensation Methods 0.000 description 3
230000005494 condensation Effects 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
235000017557 sodium bicarbonate Nutrition 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
239000004475 Arginine Substances 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
JQJPBYFTQAANLE-UHFFFAOYSA-N Butyl nitrite Chemical compound CCCCON=O JQJPBYFTQAANLE-UHFFFAOYSA-N 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
239000000556 agonist Substances 0.000 description 2
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
150000001540 azides Chemical class 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
239000003054 catalyst Substances 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
229940124558 contraceptive agent Drugs 0.000 description 2
239000003433 contraceptive agent Substances 0.000 description 2
238000001816 cooling Methods 0.000 description 2
238000010612 desalination reaction Methods 0.000 description 2
238000001035 drying Methods 0.000 description 2
239000000543 intermediate Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
230000016087 ovulation Effects 0.000 description 2
229910052763 palladium Inorganic materials 0.000 description 2
UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
239000008363 phosphate buffer Substances 0.000 description 2
230000003389 potentiating effect Effects 0.000 description 2
239000003488 releasing hormone Substances 0.000 description 2
230000001850 reproductive effect Effects 0.000 description 2
230000007017 scission Effects 0.000 description 2
238000000926 separation method Methods 0.000 description 2
CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 2
ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 2
239000003039 volatile agent Substances 0.000 description 2
JXGVXCZADZNAMJ-NSHDSACASA-N (2s)-1-phenylmethoxycarbonylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)OCC1=CC=CC=C1 JXGVXCZADZNAMJ-NSHDSACASA-N 0.000 description 1
ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
MOMFXATYAINJML-UHFFFAOYSA-N 2-Acetylthiazole Chemical group CC(=O)C1=NC=CS1 MOMFXATYAINJML-UHFFFAOYSA-N 0.000 description 1
VTKWFWXOVZIATL-NPPUSCPJSA-N 2-[[(2s)-3-(4h-imidazol-4-yl)-2-[[(2s)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]amino]acetic acid Chemical compound C([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H]1NC(=O)CC1)C1C=NC=N1 VTKWFWXOVZIATL-NPPUSCPJSA-N 0.000 description 1
JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 description 1
FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 description 1
239000004215 Carbon black (E152) Substances 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 1
SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
RNKSNIBMTUYWSH-YFKPBYRVSA-N L-prolylglycine Chemical compound [O-]C(=O)CNC(=O)[C@@H]1CCC[NH2+]1 RNKSNIBMTUYWSH-YFKPBYRVSA-N 0.000 description 1
SENJXOPIZNYLHU-IUCAKERBSA-N Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-IUCAKERBSA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
101710119110 Prolactin-1 Proteins 0.000 description 1
241000473945 Theria <moth genus> Species 0.000 description 1
HPYDSVWYXXKHRD-VIFPVBQESA-N Tyr-Gly Chemical compound [O-]C(=O)CNC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 HPYDSVWYXXKHRD-VIFPVBQESA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
150000008064 anhydrides Chemical class 0.000 description 1
238000005349 anion exchange Methods 0.000 description 1
210000004198 anterior pituitary gland Anatomy 0.000 description 1
238000003556 assay Methods 0.000 description 1
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
239000000872 buffer Substances 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
230000008602 contraction Effects 0.000 description 1
239000012043 crude product Substances 0.000 description 1
235000013365 dairy product Nutrition 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000000994 depressogenic effect Effects 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000010828 elution Methods 0.000 description 1
230000002124 endocrine Effects 0.000 description 1
239000002024 ethyl acetate extract Substances 0.000 description 1
239000012634 fragment Substances 0.000 description 1
BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical group NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 1
230000002710 gonadal effect Effects 0.000 description 1
ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
244000309465 heifer Species 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
229910000042 hydrogen bromide Inorganic materials 0.000 description 1
IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
229910000041 hydrogen chloride Inorganic materials 0.000 description 1
238000007327 hydrogenolysis reaction Methods 0.000 description 1
210000003016 hypothalamus Anatomy 0.000 description 1
208000000509 infertility Diseases 0.000 description 1
230000036512 infertility Effects 0.000 description 1
231100000535 infertility Toxicity 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
230000026045 iodination Effects 0.000 description 1
238000006192 iodination reaction Methods 0.000 description 1
108010000761 leucylarginine Proteins 0.000 description 1
238000005259 measurement Methods 0.000 description 1
APBBAQCENVXUHL-UHFFFAOYSA-N n,n-diethylethanamine;2,2,2-trifluoroacetic acid Chemical compound CCN(CC)CC.OC(=O)C(F)(F)F APBBAQCENVXUHL-UHFFFAOYSA-N 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
208000025661 ovarian cyst Diseases 0.000 description 1
208000015124 ovarian disease Diseases 0.000 description 1
239000006174 pH buffer Substances 0.000 description 1
239000002245 particle Substances 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
108010029020 prolylglycine Proteins 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000012264 purified product Substances 0.000 description 1
108010022711 pyroglutamyl-histidyl-glycine Proteins 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
238000003307 slaughter Methods 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
238000010532 solid phase synthesis reaction Methods 0.000 description 1
230000021595 spermatogenesis Effects 0.000 description 1
239000003270 steroid hormone Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
230000001629 suppression Effects 0.000 description 1
230000009897 systematic effect Effects 0.000 description 1
238000004809 thin layer chromatography Methods 0.000 description 1
ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/11—Gonadotropin; related peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Endocrinology (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

CS825868A 1982-08-06 1982-08-06 Analogues of realising factor for luteining and folliculstimulated hormon CS230614B1 (en)

Priority Applications (14)

Application Number	Priority Date	Filing Date	Title
CS825868A CS230614B1 (en)	1982-08-06	1982-08-06	Analogues of realising factor for luteining and folliculstimulated hormon
AT0271583A AT387026B (de)	1982-08-06	1983-07-26	Verfahren zur herstellung von neuen lh-fsh-releasingfaktoranaloga
SE8304158A SE456345B (sv)	1982-08-06	1983-07-27	Luteiniserings- och follikelstimulerande hormoner frigorande faktoranaloger med hog gonadotropisk verkan samt ett forfarande for framstellning derav
FR8312707A FR2531952B1 (fr)	1982-08-06	1983-08-02	Analogues a forte activite gonadotrope du facteur liberant l'hormone luteinisante et l'hormone folliculostimulante et leur procede de preparation
IT22397/83A IT1165473B (it)	1982-08-06	1983-08-02	Analoghi,ad elevata attivita' gonadotropa,di fattori che liberano ormone luteinizante e ormone follicolo-stimolante,e processo per la loro preparazione
GB08320922A GB2125408B (en)	1982-08-06	1983-08-03	Luteinizing and follicle-stimulating hormones releasing factor analogs
BE0/211294A BE897455A (fr)	1982-08-06	1983-08-03	Analogues du facteur liberant des hormones luteininsantes et stimulant les follicules ces analogues exercant une haute activite gomadotrope de meme que leur procede de preparation
DE19833328235 DE3328235A1 (de)	1982-08-06	1983-08-04	Gonadotrop hochwirksame synthetische analoga der releasingfaktoren der hormone lh und fsh und verfahren zu ihrer herstellung
JP58141977A JPS5959654A (ja)	1982-08-06	1983-08-04	ホルモン放出因子類似体及びその製造方法
CA000434011A CA1206959A (fr)	1982-08-06	1983-08-05	Hormone luteinisante et folliculostimuline liberant des facteurs analogues a une activite gonadotrope elevee et procede de preparation
CH4271/83A CH658662A5 (de)	1982-08-06	1983-08-05	Gonadotrop hochwirksame luteinierungs- und follikelstimulierungshormon-liberationsfaktoranaloge und verfahren zu deren herstellung.
HU832783A HU192962B (en)	1982-08-06	1983-08-05	Process for producing analogues with strong gonadotripic activity of factor the general formula /i/ of hormone releasing luteinizing and estron-stimulating hormones
YU1633/83A YU45144B (en)	1982-08-06	1983-08-05	Process for making new nonapeptides with high gonadotropic activity
US06/521,108 US4512923A (en)	1982-08-06	1983-08-08	Luteinizing and follicle stimulating hormones and process for the preparation thereof

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CS825868A CS230614B1 (en)	1982-08-06	1982-08-06	Analogues of realising factor for luteining and folliculstimulated hormon

Publications (1)

Publication Number	Publication Date
CS230614B1 true CS230614B1 (en)	1984-08-13

Family

ID=5404451

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CS825868A CS230614B1 (en)	1982-08-06	1982-08-06	Analogues of realising factor for luteining and folliculstimulated hormon

Country Status (14)

Country	Link
US (1)	US4512923A (fr)
JP (1)	JPS5959654A (fr)
AT (1)	AT387026B (fr)
BE (1)	BE897455A (fr)
CA (1)	CA1206959A (fr)
CH (1)	CH658662A5 (fr)
CS (1)	CS230614B1 (fr)
DE (1)	DE3328235A1 (fr)
FR (1)	FR2531952B1 (fr)
GB (1)	GB2125408B (fr)
HU (1)	HU192962B (fr)
IT (1)	IT1165473B (fr)
SE (1)	SE456345B (fr)
YU (1)	YU45144B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU194280B (en) *	1985-10-22	1988-01-28	Richter Gedeon Vegyeszet	Process for producing new gonadoliberin analogues of high effectivity and pharmaceutical compositions containing them
US4762717A (en) *	1986-03-21	1988-08-09	The General Hospital Corporation	Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
DE4305225A1 (de) *	1993-02-19	1994-08-25	Asta Medica Ag	Neues Herstellverfahren für Cetrorelix Lyophilisat
US6828415B2 (en) *	1993-02-19	2004-12-07	Zentaris Gmbh	Oligopeptide lyophilisate, their preparation and use
CA2192782C (fr)	1995-12-15	2008-10-14	Nobuyuki Takechi	Production de microsphere
CA2192773C (fr)	1995-12-15	2008-09-23	Hiroaki Okada	Obtention d'une preparation a liberation prolongee pour injection
US5972895A (en) *	1996-12-11	1999-10-26	A. Glenn Braswell	Composition and method for increasing growth hormone levels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT347054B (de) *	1973-09-29	1978-12-11	Takeda Chemical Industries Ltd	Verfahren zur herstellung von neuen nonapeptidamid-derivaten
GB1532211A (en) *	1974-10-25	1978-11-15	Wellcome Found	Lh-rh peptide analogues
US4101537A (en) *	1977-04-07	1978-07-18	Parke, Davis & Company	Octapeptides and methods for their production
US4124577A (en) *	1977-06-13	1978-11-07	Warner-Lambert	Nonapeptides and methods for their production
IT1149971B (it) *	1979-06-11	1986-12-10	Syntex Inc	Derivati nonapeptide e decapeptide dell'ormone che rilascia l'ormone luteinizzante

1982
- 1982-08-06 CS CS825868A patent/CS230614B1/cs unknown
1983
- 1983-07-26 AT AT0271583A patent/AT387026B/de not_active IP Right Cessation
- 1983-07-27 SE SE8304158A patent/SE456345B/sv not_active IP Right Cessation
- 1983-08-02 IT IT22397/83A patent/IT1165473B/it active
- 1983-08-02 FR FR8312707A patent/FR2531952B1/fr not_active Expired
- 1983-08-03 BE BE0/211294A patent/BE897455A/fr unknown
- 1983-08-03 GB GB08320922A patent/GB2125408B/en not_active Expired
- 1983-08-04 DE DE19833328235 patent/DE3328235A1/de not_active Ceased
- 1983-08-04 JP JP58141977A patent/JPS5959654A/ja active Pending
- 1983-08-05 CA CA000434011A patent/CA1206959A/fr not_active Expired
- 1983-08-05 YU YU1633/83A patent/YU45144B/xx unknown
- 1983-08-05 HU HU832783A patent/HU192962B/hu unknown
- 1983-08-05 CH CH4271/83A patent/CH658662A5/de not_active IP Right Cessation
- 1983-08-08 US US06/521,108 patent/US4512923A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
IT8322397A1 (it)	1985-02-02
JPS5959654A (ja)	1984-04-05
DE3328235A1 (de)	1984-04-05
YU45144B (en)	1992-03-10
CH658662A5 (de)	1986-11-28
GB2125408A (en)	1984-03-07
ATA271583A (de)	1988-04-15
IT1165473B (it)	1987-04-22
YU163383A (en)	1986-06-30
FR2531952B1 (fr)	1988-07-22
US4512923A (en)	1985-04-23
GB8320922D0 (en)	1983-09-07
CA1206959A (fr)	1986-07-02
SE8304158D0 (sv)	1983-07-27
IT8322397A0 (it)	1983-08-02
FR2531952A1 (fr)	1984-02-24
HU192962B (en)	1987-08-28
BE897455A (fr)	1983-12-01
GB2125408B (en)	1986-06-18
SE8304158L (sv)	1984-02-07
SE456345B (sv)	1988-09-26
AT387026B (de)	1988-11-25

Publication	Publication Date	Title
KR930008095B1 (ko)	1993-08-25	Lhrh 길항제로서 유용한 lhrh의 노나펩타이드 및 데카펩타이드 동족체
KR910002550B1 (ko)	1991-04-24	Lhrh의 노나펩타이드 및 데카펩타이드 동족체 및 이의 제조방법
US3992365A (en)	1976-11-16	Agonist analogues of luteinizing hormone releasing hormone
US4317815A (en)	1982-03-02	LH-RH Antagonists
FI60553C (fi)	1982-02-10	Foerfarande foer framstaellning av ovulationsframkallande nonapeptidamidderivat
SE437993B (sv)	1985-03-25	Sett att framstella en polypeptid med luliberin-agonist-egenskaper
SI8011553A8 (sl)	1998-02-28	Postopek za pripravo nonapeptidnih in dekapeptidnih derivatov hormonov za sproščanje luteinizirajočega hormona
HU213098B (en)	1997-02-28	Process for producing decapeptides antagonistic to hormone for releazing lutheinizing-hormone and pharmaceutical compositions containing them as active components
EP0192492B1 (fr)	1992-01-02	Peptides contenant une chaîne latérale cétone aliphatique-aromatique
EP0081877B1 (fr)	1986-04-30	Antagonistes de LH-RH
CA1057743A (fr)	1979-07-03	Composes analogues de type lh-rh
CS230614B1 (en)	1984-08-13	Analogues of realising factor for luteining and folliculstimulated hormon
AU662496B2 (en)	1995-09-07	LHRH-antagonists
US4721775A (en)	1988-01-26	Effective peptides related to the luteinizing hormone releasing hormone from L-amino acids
Yanaihara et al.	1973	Synthesis and biological evaluation of LH-and FSH-releasing hormone and its analogs
US3888838A (en)	1975-06-10	Decapeptide having luteinizing hormone (lh)-and follicle stimulating hormone (fsh)-releasing activity, salts and compositions thereof, a process for preparing same, and intermediates therefor
US4083967A (en)	1978-04-11	Nona- and decapeptides
HU185427B (en)	1985-02-28	Process for preparing antagonists of hormone releasing luteinizing hormone
US4111923A (en)	1978-09-05	Octapeptides and methods for their production
US4261887A (en)	1981-04-14	Peptide compositions
US4948873A (en)	1990-08-14	Gonadoliberine analogues of high activity
JP2672677B2 (ja)	1997-11-05	Ｌｈｒｈ同族体
Burov et al.	1982	Synthesis of biologically active analogs of luliberin with shortened amino acid sequences
Sivanandaiah et al.	1989	Improved solid phase synthesis of luteinizing hormone releasing hormone analogues using 9-fluorenylmethyloxycarbonyl amino acid active esters and catalytic transfer hydrogenation with minimal side-chain protection and their biological activities
JPS59501985A (ja)	1984-11-29	生殖腺機能に影響を及ぼすペプチド類